Dell’osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. 2013;28(1):7–20.

Article  PubMed  Google Scholar 

Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction. 2007;102(4):616–22.

Article  PubMed  Google Scholar 

Gelkopf M, Bleich A, Hayward R, Bodner G, Adelson M. Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug Alcohol Depend. 1999;55(1–2):63–8.

Article  CAS  PubMed  Google Scholar 

Backmund M, Meyer K, Henkel C, Soyka M, Reimer J, Schütz CG. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. J Addict Dis. 2008;24(4):17–29.

Article  Google Scholar 

Franklyn AM, Eibl JK, Gauthier G, Pellegrini D, Lightfoot NK, Marsh DC. The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm Reduct J. 2017;14(1):1–9.

Google Scholar 

Chen KW, Berger CC, Forde DP, D’Adamo C, Weintraub E, Gandhi D. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry. 2011;11(1):1–7.

Article  Google Scholar 

Vogel M, Dürsteler-MacFarland KM, Walter M, Strasser J, Fehr S, Prieto L, et al. Prolonged use of benzodiazepines is associated with childhood trauma in opioid-maintained patients. Drug Alcohol Depend. 2011;119(1–2):93–8.

Article  CAS  PubMed  Google Scholar 

Eiroa-Orosa FJ, Haasen C, Verthein U, Dilg C, Schäfer I, Reimer J. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. Drug Alcohol Depend. 2010;112(3):226–33.

Article  PubMed  Google Scholar 

Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008;27(3):37–48.

Article  PubMed  Google Scholar 

Briand Madrid L, Morel S, Ndiaye K, Mezaache S, Rojas Castro D, Mora M, et al. Factors associated with perceived loss of libido in people who inject opioids: results from a community-based survey in France. Drug Alcohol Depend. 2018;1(190):121–7.

Article  Google Scholar 

Abrahamsson T, Berge J, Öjehagen A, Håkansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment—a nation-wide register-based open cohort study. Drug Alcohol Depend. 2017;1(174):58–64.

Article  Google Scholar 

Lavie E, Fatséas M, Denis C, Auriacombe M. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence. Drug Alcohol Depend. 2009;99(1–3):338–44.

Article  CAS  PubMed  Google Scholar 

Strada L, Schmidt CS, Rosenkranz M, Verthein U, Scherbaum N, Reimer J, et al. Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: a cross-sectional study. Subst Abuse Treat Prev Policy. 2019;14(1):1–14.

Article  Google Scholar 

Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, et al. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Subst Abuse Treat Prev Policy. 2020;15(1):1–12.

Article  Google Scholar 

Vogel M, Knöpfli B, Schmid O, Prica M, Strasser J, Prieto L, et al. Treatment or “high”: benzodiazepine use in patients on injectable heroin or oral opioids. Addict Behav. 2013;38(10):2477–84.

Article  PubMed  Google Scholar 

Stein MD, Kanabar M, Anderson BJ, Lembke A, Bailey GL. Reasons for benzodiazepine use among persons seeking opioid detoxification. J Subst Abuse Treat. 2016;1(68):57–61.

Article  Google Scholar 

Fatséas M, Lavie E, Denis C, Auriacombe M. Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients. J Subst Abuse Treat. 2009;37(4):407–11.

Article  PubMed  Google Scholar 

Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231–44.

Article  CAS  PubMed  Google Scholar 

Fatséas M, Denis C, Lavie E, Auriacombe M. Relationship between anxiety disorders and opiate dependence— a systematic review of the literature: implications for diagnosis and treatment. J Subst Abuse Treat [Internet]. 2010;38(3):220–30.

Article  PubMed  Google Scholar 

Liebrenz M, Boesch L, Stohler R, Caflisch C. Agonist substitution—a treatment alternative for high-dose benzodiazepine-dependent patients? Addiction. 2010;105(11):1870–4.

Article  PubMed  Google Scholar 

Macleod J, Steer C, Tilling K, Cornish R, Marsden J, Millar T, et al. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLoS Med. 2019;16(11): e1002965.

Article  PubMed  PubMed Central  Google Scholar 

Park TW, Larochelle MR, Saitz R, Wang N, Bernson D, Walley AY. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Addiction. 2020;115(5):924–32.

Article  PubMed  PubMed Central  Google Scholar 

Park TW, Sikov J, della Bitta V, Saitz R, Walley AY, Drainoni ML. “It could potentially be dangerous… but nothing else has seemed to help me.”: Patient and clinician perspectives on benzodiazepine use in opioid agonist treatment. J Subst Abuse Treat. 2021;131:108455.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vorma H, Naukkarinen H, Sarna S, Kuoppasalmi K. Symptom severity and quality of life after benzodiazepine withdrawal treatment in participants with complicated dependence. Addict Behav. 2004;29(6):1059–65.

Article  PubMed  Google Scholar 

Schmid O. Einfluss einer Substitutionsbehandlung auf die Lebensqualität. Herbert Utz Verlag GmbH; 2014. 1–275 p.

Hardt J, Gerbershagen HU. Cross-validation of the SCL-27: a short psychometric screening instrument for chronic pain patients. Eur J Pain. 2001;5(2):187–97.

Article  CAS  PubMed  Google Scholar 

Verthein U, Beck T, Haasen C, Reimer J. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study. Eur Addict Res. 2015;21(2):97–104.

Article  PubMed  Google Scholar 

Kuhl HC, Hartwig I, Petitjean S, Müller-Spahn F, Margraf J, Bader K. Validation of the Symptom Checklist SCL-27 in psychiatric patients: Psychometric testing of a multidimensional short form. Int J Psychiatry Clin Pract. 2010;14(2):145–9. https://doi.org/10.3109/13651501003660484.

Article  PubMed  Google Scholar 

Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.

Article  Google Scholar 

Lehr D, Hillert A, Schmitz E, Sosnowsky N. Screening depressiver Störungen mittels Allgemeiner Depressions-Skala (ADS-K) und State-Trait Depressions Scales (STDS-T). Diagnostica. 2008;54(2):61–70.

Article  Google Scholar 

Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, et al. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006;63(2):219–28.

Article  CAS  PubMed  Google Scholar 

Romero-Gonzalez M, Shahanaghi A, DiGirolamo GJ, Gonzalez G. Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders. Am J Addict. 2017;26(8):838–44.

Article  PubMed  PubMed Central  Google Scholar 

Priebe S, Gruyters T, Heinze M, Hoffmann C, Jakel A. Subjektive Evaluationskriterien in der psychiatrischen Versorgung—Erhebungsmethoden für Forschung und Praxis. Psychiatr Prax. 1995;22(4):140–4.

CAS  PubMed  Google Scholar 

Oliver JPJ, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatr Epidemiol. 1997;32(2):76–83.

Article  CAS  PubMed  Google Scholar 

Giacomuzzi SM, Riemer Y, Ertl M, Kemmler G, Richter R, Rössler H, et al. Lebensqualität: methadon vs. retardiertes Morphinsulfat—eine Vergleichsstudie. Suchtmedizin. 2001;3(1):1–7.

Google Scholar 

Schneider J, Wooff D, Carpenter J, Brandon T, McNiven F. Community mental healthcare in England: associations between service organisation and quality of life. Health Soc Care Community. 2002;10(6):423–34.

Article  PubMed  Google Scholar 

Van Hecke N, Meulewaeter F, Rowaert S, van Nieuwenhuizen C, Van Damme L, Vanderplasschen W, et al. Adolescents’ quality of life and mental health needs during the initial phase in a closed institution. Int J Forensic Ment Health. 2021;21(2):107–19.

Article  Google Scholar 

Beubler E, Haltmayer H, Springer A. Opiatabhängigkeit: interdisziplinäre Aspekte für die Praxis. Springer-Verlag; 2007. 185–204 p.

Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18(3):249–55.

Article  PubMed  Google Scholar 

Poser W, Poser S. Medikamente-Mißbrauch und Abhängigkeit: Entstehung-Verlauf-Behandlung; 17 Tabellen. Thieme; 1996.

Bizzarri J, Rucci P, Vallotta A, Girelli M, Scandolari A, Zerbetto E, et al. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse. 2009;40(12):1765–76.

Article  Google Scholar 

Carpentier PJ, Krabbe PFM, Van Gogh MT, Knapen LJM, Buitelaar JK, De Jong CAJ. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18(6):470–80.

Article  PubMed  Google Scholar 

Tamburin S, Federico A, Faccini M, Casari R, Morbioli L, Sartore V, et al. Determinants of quality of life in high-dose benzodiazepine misusers. Int J Environ Res Public Health. 2017;14(1):38.